FDA News Digest for October 3, 2005

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: Message

FDA News Digest

October 3, 2005

__________________________________________________

 

IN THIS WEEK'S ISSUE

 

--  FDA Warns of Suicidal Thoughts in Users of ADHD Drug Strattera

--  Rule Finalized for Requiring Registration of Food Facilities

--  2005 Food Code Updates Food Safety Guidelines for Industry

--  Latest FDA Consumer Magazine Available Online

--  Recalls/Safety Alerts
--  Congressional Testimony
--  Recent Speeches

--  Upcoming Public Meetings

--  Question of the Week

___________________________________________________

 

FDA Warns of Suicidal Thoughts in Users of ADHD Drug Strattera

 

Following review of more than a dozen clinical trials, FDA is alerting health care professionals about reports of suicidal thinking in children and adolescents who take Strattera, a drug for attention deficit hyperactivity disorder. The agency advises close monitoring of patients on the drug for suicidal thoughts and other unusual changes in behavior, especially when the dose is changed. More than two million patients have used Strattera since the drug was first marketed in 2002.

http://www.fda.gov/bbs/topics/NEWS/2005/NEW01237.html

 

Rule Finalized for Requiring Registration of Food Facilities

 

FDA has issued a final rule requiring registration of all domestic and foreign facilities that manufacture, process, pack, or hold food for consumption in the United States. The rule will help FDA identify and quickly locate food facilities in the event of deliberate or accidental contamination of the food supply. The rule is one of five regulations FDA has issued to implement the Bioterrorism Act of 2002.

http://www.fda.gov/bbs/topics/news/2005/new01236.html

 

2005 Food Code Updates Food Safety Guidelines for Industry

 

FDA has issued the 2005 Food Code, which contains the latest science-based information on food safety for food service organizations. About 3,000 regulatory agencies use the Food Code as a reference to aid in oversight of food safety in restaurants, grocery stores, nursing homes, and other retail and institutional settings.

http://www.fda.gov/bbs/topics/news/2005/new01235.html

 

To view an archive of past FDA news releases, go to

http://www.fda.gov/opacom/hpnews.html.

 

To access the RSS feed of FDA news releases, go to

http://www.fda.gov/bbs/topics/news/rssPress.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

___________________________________________________

 

Latest FDA Consumer Magazine Available Online

 

The September-October 2005 issue of FDA Consumer has articles on these topics:

 

--  Saving money on prescription drugs -- These strategies can help lower your medicine bill.

--  Epilepsy - New research is improving our understanding of the underlying causes of this disease.

--  Mammograms -- They can detect breast cancer early, when it's most treatable.

--  Choking hazards -- How to reduce choking risks for your child.

--  Pediatric medical devices -- Specially designed devices can meet children's short- and long-term needs.

--  Urinary incontinence -- Treatments are available to cure or improve this frustrating problem.

--  New heart drug for black patients -- BiDil can reduce death and hospitalization.

 

The issue is online at http://www.fda.gov/fdac/505_toc.html.

 

Subscribe to the print version of FDA Consumer:  http://www.fda.gov/fdac/orderform/fdap.html

_____________________________________________________

 

RECALLS/SAFETY ALERTS

 

Recalls:

 

All lots of injectable chemotherapy drug Fluorouracil; 50 mg/10 mL (500 mg/10 mL single dose vial)

Reason for recall: possible glass particles in the vials

http://www.fda.gov/medwatch/safety/2005/safety05.htm#Fluorouracil

 

Safety Alerts:

 

FDA is warning consumers not to eat certain pre-packaged Dole salad products because they have been associated with an outbreak of E. coli O157:H7 in Minnesota. Affected products include certain lots of Classic Romaine, American Blend, and Greener Selection, which Dole is recalling. No other Dole salad products are involved.
 
FDA is alerting consumers and health professionals about five reports of Guillain Barre Syndrome following treatment with Menactra (Meningococcal Conjugate Vaccine A, C, Y, and W135). Guillain Barre Syndrome is a serious neurological disorder that causes increasing weakness in the legs and arms. Menactra treats meningococcal infection, a major cause of bacterial meningitis.
 

 

For a list of recalls, market withdrawals, and safety alerts involving FDA-regulated

products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.

 

To access the RSS feed of FDA recalls information, go to

http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

___________________________________________________

 

CONGRESSIONAL TESTIMONY

 

Sept. 29 -- FDA Office of Medical Policy Deputy Director Rachel E. Behrman, M.D., appeared before the Senate Committee on Aging.

Subject: the impact of direct-to-consumer drug advertising on seniors' health and health care costs

http://www.fda.gov/ola/2005/idcda0929.html

 

To view an archive of past testimony by FDA officials, go to

http://www.fda.gov/ola/listing.html.

____________________________________________________

 

RECENT SPEECHES

 

Sept. 28 -- FDA Deputy Commissioner for Medical and Scientific Affairs Scott Gottlieb, M.D., spoke before the National Press Club.

Subject: "Dismantling Barriers to Better Medical Information" 

http://www.fda.gov/oc/speeches/2005/npc0928.html

 

To view an archive of past speeches by FDA officials, go to

http://www.fda.gov/speeches/speechli.htm.

____________________________________________________

 

UPCOMING PUBLIC MEETINGS
 

Oct. 11 -- Cardiac Safety and the Critical Pathway Initiative Think Tank symposium offers an opportunity to participate in helping to shape the future of cardiac safety testing and its impact on drug and device development.

Location: Bethesda, Md.

https://banquo.duhs.duke.edu/dcri/coresearchreg.nsf/core

 

Oct. 11-12 -- Dental Products Panel of the Medical Devices Advisory Committee

Under discussion: recommendations on classification of seven unclassified dental devices

Location: Gaithersburg, Md.

http://www.fda.gov/oc/advisory/accalendar/2005/cdrh12518dd10111205.html

 

For a list of FDA meetings, seminars, and other public events, go to

http://www.fda.gov/opacom/hpmeetings.html.

__________________________________________________

QUESTION OF THE WEEK

 

What is liposuction?

 

Liposuction is a surgical procedure intended to remove fat deposits and shape the body. Fat is removed from under the skin with the use of a vacuum-suction canula (a hollow pen-like instrument) or using an ultrasonic probe that breaks fat up into small pieces and then removes it with suction. Persons with localized fat may decide to have liposuction to remove fat from that area. Liposuction is intended to shape the body and is not recommended for weight loss.

Liposuction may be performed on the abdomen, hips, thighs, calves, arms, buttocks, back, neck, or face. A liposuction procedure may include more than one site, for instance, the abdomen, back, and thighs all on the same day.

Liposuction is also used to reduce breast size in men with large breasts (gynecomastia) or to remove fat tumors (lipomas), but it is most commonly used for cosmetic body shaping.  

Want to learn more? Go to http://www.fda.gov/cdrh/liposuction/.                                                                                                                                            __________________________________________________

HOW'S YOUR KNOWLEDGE of health topics such as generic drugs, mammograms, epilepsy, or pediatric drugs? Find out by taking our online quiz at http://www.fda.gov/fdac/quiz/onlinequiz25_js.html.

__________________________________________________

 

Thanks for subscribing to FDA News Digest. Our next posting will be October 11.

 

To subscribe to or unsubscribe from this list, go to

http://list.nih.gov/cgi-bin/wa?SUBED1=fda-newsdigest-l&A=1.


[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux